A new frontier AI company called Recursive Superintelligence has emerged from stealth with $650 million in funding and an ...

If you are a community college student building Python skills alongside microcontrollers and robotics projects, the PCEP-30-02 certification is your fastest, most credible way to validate those skills ...

A retired U.S. Air Force major general has been missing for two weeks, after vanishing late last month in New Mexico, authorities said. William "Neil" McCasland, 68, was last seen at his home in ...

Type to search articles, cases, and authors. Press ↵ to view all results. The Supreme Court has taken a lot of heat in recent months over the high rate at which it has sided with the Trump ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

RXRX has upcoming data in H2'25 from the TUPELO trial of REC-4881 in familial adenomatous polyposis. The company will also report data from the ELUCIDATE trial of REC-617 in H2'25. A previous update ...

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. 10 stocks we like better than ...

During the last three months, 4 analysts shared their evaluations of Recursion Pharmaceuticals (NASDAQ:RXRX), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of ...

The company laid out its restructuring plans in a regulatory document. These include a workforce reduction of around 20%. Before market open, Recursion disclosed in a tersely worded regulatory filing ...